Purchase Order 75N95019P00032
- Not listed
- This federal contract award to Transnetyx, Inc. is for PCR for genotyping services, with a ceiling value of $14,000 and a completion date of February 7, 2025. The contract is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx, Inc., a for-profit organization specializing in automated genotyping, DNA extraction, and bioinformatics services, has extensive experience supporting...
- This is a $20,000 firm-fixed-price purchase order awarded to Transnetyx, Inc. by the National Institute on Drug Abuse, a component of the Department of Health and Human Services. The contract is for Transnetyx's genotyping services to support biomedical research efforts. Transnetyx, a for-profit organization, specializes in DNA extraction, multi-gene analysis, bioinformatics, and automated genotyping services, primarily serving various NIH institutes. The contract is not set-aside. Transnetyx...
- This federal contract award to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services, was issued by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services. The $14,000.00 Blanket Purchase Agreement (BPA) Call contract provides genotyping services to support scientific research, with a period of performance from April 2017 to April 2018. The contract was not set aside and was awarded...
- This federal contract award is for GENOTYPING SERVICES provided by Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The contract, valued at $9,847.80, was awarded on February 23, 2017 by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services. The contract has an ultimate completion date of February 22, 2018 and is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Transnetyx, Inc. for genotyping testing services from December 13, 2018 to December 12, 2019. The potential value of this award is $5,313.70. There was no set-aside designation for this contract, and the place of performance is Baltimore, Maryland. Transnetyx, Inc. is a for-profit organization...
- This federal contract award is for genotyping services provided by Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $7,542.05 Blanket Purchase Agreement (BPA) Call contract was awarded on December 8, 2017 by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services. The contract has a firm fixed price pricing type and an ultimate completion date of December 1, 2023. Transnetyx has...
- This firm-fixed-price purchase order, valued at $24,487.45, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services to support biomedical research. The contract, which has no set-aside designation, is for genotyping testing services to support NIDA's research initiatives. Transnetyx has held numerous federal contracts to provide genomic...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to Transnetyx, Inc. The $290,259.80 contract is for genotyping support services, including DNA extraction, multi-gene analysis, bioinformatics, and genotyping. Transnetyx, a for-profit organization, has provided genetic testing and sequencing services to various HHS agencies in the past to support research on neurological...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Transnetyx, Inc. The contract, valued at $24,999.00, is for automated genotyping services to support research examining the behavior and cellular mechanisms of learning in addiction. Transnetyx, a for-profit organization, provides a range of genomic services to federal agencies, including DNA extraction, gene analysis, and...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $15,000 contract is for genotyping services during fiscal year 2019 and has a firm fixed price. Transnetyx has established itself as a critical provider of genetic testing services for various national research institutions,...
Transnetyx, Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse for $19,452.25 to provide genotype testing services. The award supports the agency's research efforts through March 2025 without a set-aside designation. As the prime contractor, Transnetyx will leverage its expertise in automated genotyping and DNA analysis to extract and sequence genes from research samples. This builds upon Transnetyx's past performance conducting similar genetic testing for NIH institutes studying neurological disorders, substance abuse, and medical countermeasures. The company also functions as a subcontractor through vehicles like indefinite delivery contracts valued between $1.4 million to $7 million to provide genotyping and bioinformatics data in support of NIH research into environmental health and age-related diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($548) | 3/6/24 | |
| Not listed | Not listed | $20.0k | 10/30/18 |